Tex. Health & Safety Code § 442.001 · Subchapter A. GENERAL PROVISIONS
DEFINITIONS.
Text — Current through the 89th 2nd Called Legislative Session, 2025
In this chapter:
(1) "Donor" means an individual, a prescription drug manufacturer, or a health care facility, including a pharmacy, that donates unused prescription drugs under this chapter to a participating provider.
(2) "Health care facility" means a facility that provides health care services to patients and maintains a pharmacy in the facility. The term includes the following facilities if a pharmacy is maintained in the facility:
(A) a general or special hospital as defined by Chapter 241;
(B) an ambulatory surgical center licensed under Chapter 243; and
(C) an institution licensed under Chapter 242.
(3) "Health care professional" means an individual licensed, certified, or otherwise authorized to administer health care and prescribe prescription drugs, for profit or otherwise, in the ordinary course of business or professional practice. The term does not include a health care facility.
(4) "Participating provider" means a health care facility or pharmacy, or a pharmacist who is an employee of the facility or pharmacy, that elects to participate in the collection and redistribution of donated prescription drugs under this chapter.
(5) "Pharmacist" means a person licensed under Chapter 558, Occupations Code.
(6) "Pharmacy" means an entity licensed under Chapter 560, Occupations Code.
(6-a) "Prepackage" means the act of repackaging and relabeling varying quantities of prescription drugs from a manufacturer's original commercial container into a prescription container, unit-dose packaging, or a multi-compartment container for a pharmacist to dispense to a consumer.
(7) "Prescription drug" has the meaning assigned by Section 551.003, Occupations Code.
(8) "Recipient" means an individual who voluntarily receives donated prescription drugs under this chapter.
(9) "Tamper-evident" means packaging that allows for detection of unauthorized access to a prescription drug.
Notes and commentary — not statutory text
History
Added by Acts 2017, 85th Leg., R.S., Ch. 485 (H.B. 2561), Sec. 7(a), eff. September 1, 2017.
Amended by:
Acts 2023, 88th Leg., R.S., Ch. 761 (H.B. 4331), Sec. 1, eff. September 1, 2023.
Acts 2023, 88th Leg., R.S., Ch. 762 (H.B. 4332), Sec. 1, eff. September 1, 2023.
Source of truth
- Edition
- Current through the 89th 2nd Called Legislative Session, 2025
- Official file
- https://statutes.capitol.texas.gov/Docs/HS/htm/HS.442.htm
- Text hash
- sha256 ad7c5944aaaec9ebbd195c7032dc454f58a7ce7b8385ebc226b4c24d5415f362
- Composed by
- compose_tx.py 2026-10-05: the Legislative Council's chapter files read in document order; verify_tx.py's independent reading (lxml DOM walk) agrees character for character
This section cites
Provisions in this library that the text above cites, as it prints each citation. A range cited as “ss. 61.13-61.16” links its first and last provisions.
Health and Safety Code
Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.